• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过阻断 MEK-ERK 信号通路,黄酮类化合物黄芩素优先抑制肝癌。

Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling.

机构信息

Department of General Surgery, Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an 710004, P.R. China.

出版信息

Int J Oncol. 2012 Sep;41(3):969-78. doi: 10.3892/ijo.2012.1510. Epub 2012 Jun 6.

DOI:10.3892/ijo.2012.1510
PMID:22684543
Abstract

Baicalein is a purified flavonoid extracted from the roots of Scutellaria baicalensis or Scutellaria radix. Although previous studies have suggested that Baicalein possesses an in vitro anti-hepatocellular carcinoma activity, its in vivo effects and mechanisms of action are still not completely understood. In this study, Baicalein at concentrations of 40-120 µM exhibited significant cytotoxicity to three hepatocellular carcinoma (HCC) cell lines but marginal cytotoxicity to a normal liver cell line in vitro. Compared to a standard chemotherapy drug, 5-fluorouracil (5-FU), Baicalein had greater effect on HCC cells but less toxicity on normal liver cells. Treatment with Baicalein dramatically reduced mitochondrial transmembrane potential, and activated caspase-9 and caspase-3. Blockade of Baicalein-induced apoptosis with a pan-caspase inhibitor partially attenuated Baicalein-induced growth inhibition in HCC. Baicalein treatment significantly inhibited tumor growth of HCC xenografts in mice. Induction of apoptosis was demonstrated in Baicalein-treated xenograft tumors by the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Furthermore, Baicalein treatment dramatically decreased the levels of phosphorylation of MEK1, ERK1/2 and Bad in vitro and in vivo. Overexpression of human MEK1 partially blocked Baicalein-induced growth inhibition. Consequently, these findings suggest that Baicalein preferentially inhibits HCC tumor growth through inhibition of MEK-ERK signaling and by inducing intrinsic apoptosis.

摘要

黄芩素是从黄芩或黄芩根中提取的一种纯化黄酮类化合物。虽然先前的研究表明黄芩素有体外抗肝癌活性,但它在体内的作用和机制仍不完全清楚。在这项研究中,黄芩素在 40-120µM 的浓度下对三种肝癌(HCC)细胞系表现出显著的细胞毒性,但对体外正常肝细胞系仅有轻微的细胞毒性。与标准化疗药物 5-氟尿嘧啶(5-FU)相比,黄芩素对 HCC 细胞的作用更大,但对正常肝细胞的毒性更小。黄芩素处理显著降低了线粒体跨膜电位,并激活了 caspase-9 和 caspase-3。用泛半胱天冬酶抑制剂阻断黄芩素诱导的细胞凋亡部分减弱了黄芩素诱导的 HCC 细胞生长抑制。黄芩素处理显著抑制了 HCC 异种移植瘤在小鼠中的生长。末端脱氧核苷酸转移酶 dUTP 缺口末端标记(TUNEL)检测显示,黄芩素处理诱导了异种移植瘤中的细胞凋亡。此外,黄芩素处理在体外和体内均显著降低了 MEK1、ERK1/2 和 Bad 的磷酸化水平。人 MEK1 的过表达部分阻断了黄芩素诱导的生长抑制。因此,这些发现表明,黄芩素通过抑制 MEK-ERK 信号通路和诱导内在凋亡,优先抑制 HCC 肿瘤生长。

相似文献

1
Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling.通过阻断 MEK-ERK 信号通路,黄酮类化合物黄芩素优先抑制肝癌。
Int J Oncol. 2012 Sep;41(3):969-78. doi: 10.3892/ijo.2012.1510. Epub 2012 Jun 6.
2
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.索拉非尼阻断RAF/MEK/ERK通路,抑制肿瘤血管生成,并在肝癌模型PLC/PRF/5中诱导肿瘤细胞凋亡。
Cancer Res. 2006 Dec 15;66(24):11851-8. doi: 10.1158/0008-5472.CAN-06-1377.
3
The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.阿霉素对MEK-ERK信号传导的影响预示着其在肝癌中的疗效。
J Surg Res. 2008 Dec;150(2):219-26. doi: 10.1016/j.jss.2008.01.029. Epub 2008 Mar 3.
4
The growth inhibition of liver cancer cells by paclitaxel and the involvement of extracellular signal-regulated kinase and apoptosis.紫杉醇对肝癌细胞的生长抑制作用以及细胞外信号调节激酶和细胞凋亡的参与
Oncol Rep. 2007 May;17(5):1195-200.
5
Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells.穿心莲内酯通过涉及p53参与的半胱天冬酶-8依赖性线粒体途径增强5-氟尿嘧啶诱导的肝癌(SMMC-7721)细胞凋亡。
Cancer Lett. 2009 Apr 18;276(2):180-8. doi: 10.1016/j.canlet.2008.11.015. Epub 2008 Dec 20.
6
Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis.丝裂原活化蛋白激酶(MAPK)激酶(MEK)-MAPK在肝细胞癌中的过表达:其在肿瘤进展和凋亡中的作用。
BMC Gastroenterol. 2003 Aug 8;3:19. doi: 10.1186/1471-230X-3-19.
7
MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting SH3GL1 and negatively regulating EGFR/ERK/NF-κB signaling.miR-3663-3p 通过靶向 SH3GL1 负调控 EGFR/ERK/NF-κB 信号通路参与黄芩素抗肝癌增殖活性。
Toxicol Appl Pharmacol. 2021 Jun 1;420:115522. doi: 10.1016/j.taap.2021.115522. Epub 2021 Apr 8.
8
Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα and MEK/ERK1/2 signaling pathways in human non-small cell lung cancer cells.黄芩素通过AMPKα与MEK/ERK1/2信号通路的相互作用,增加人非小细胞肺癌细胞中RUNX3和FOXO3a的表达及相互作用。
J Exp Clin Cancer Res. 2015 May 7;34(1):41. doi: 10.1186/s13046-015-0160-7.
9
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).AZD6244 增强了索拉非尼在人肝癌(HCC)异位和原位模型中的抗肿瘤活性。
J Hepatol. 2010 Jan;52(1):79-87. doi: 10.1016/j.jhep.2009.10.008. Epub 2009 Oct 28.
10
Baicalein inhibits hepatocellular carcinoma cells through suppressing the expression of CD24.黄芩素通过抑制CD24的表达来抑制肝癌细胞。
Int Immunopharmacol. 2015 Dec;29(2):416-422. doi: 10.1016/j.intimp.2015.10.021. Epub 2015 Nov 6.

引用本文的文献

1
Therapeutic efficacy of baicalein and 6-(methylsulfinyl)hexyl isothiocyanate, alone or in combination with 5-fluorouracil, in the treatment of colorectal cancer.黄芩素和6-(甲基亚磺酰基)己基异硫氰酸酯单独或与5-氟尿嘧啶联合用于治疗结直肠癌的疗效。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 10. doi: 10.1007/s00210-025-04274-w.
2
Baicalein, a natural flavonoid in gastrointestinal cancers treatment: recent trends and future perspectives.黄芩素,一种用于胃肠道癌症治疗的天然黄酮类化合物:最新趋势与未来展望。
Med Oncol. 2024 Dec 24;42(1):35. doi: 10.1007/s12032-024-02587-z.
3
Network pharmacology and bioinformatic integrative analysis reveals candidate gene targets and potential therapeutic of East Kalimantan propolis against hepatocellular carcinoma.
网络药理学和生物信息学综合分析揭示了东加里曼丹蜂胶抗肝细胞癌的候选基因靶点和潜在治疗方法。
Heliyon. 2024 Oct 19;10(21):e39142. doi: 10.1016/j.heliyon.2024.e39142. eCollection 2024 Nov 15.
4
Evidence and possible mechanism of and its bioactive compounds for hepatocellular carcinoma treatment.姜黄及其生物活性化合物治疗肝细胞癌的证据和可能机制。
Ann Med. 2023;55(2):2247004. doi: 10.1080/07853890.2023.2247004. Epub 2024 Jan 17.
5
The Multifaceted Role of Baicalein in Cancer Management through Modulation of Cell Signalling Pathways.黄芩素通过调节细胞信号通路在癌症管理中的多方面作用。
Molecules. 2022 Nov 18;27(22):8023. doi: 10.3390/molecules27228023.
6
Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview.通过生物活性天然产物靶向Ras-ERK级联反应用于癌症的潜在治疗:最新综述
Cancer Cell Int. 2022 Aug 8;22(1):246. doi: 10.1186/s12935-022-02666-z.
7
An overview of pharmacological activities of baicalin and its aglycone baicalein: New insights into molecular mechanisms and signaling pathways.黄芩苷及其苷元黄芩素的药理活性概述:分子机制和信号通路的新见解
Iran J Basic Med Sci. 2022 Jan;25(1):14-26. doi: 10.22038/IJBMS.2022.60380.13381.
8
Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma.中药及其活性成分在肝细胞癌治疗中的现状
J Hepatocell Carcinoma. 2022 Feb 9;9:41-56. doi: 10.2147/JHC.S346047. eCollection 2022.
9
Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights.抗肝癌生物分子:分子靶点洞察。
Int J Mol Sci. 2021 Oct 6;22(19):10774. doi: 10.3390/ijms221910774.
10
Anti-cancer properties of specific Chinese herbal medicines for hepatocellular carcinoma treatment.用于治疗肝细胞癌的特定中草药的抗癌特性。
Eur J Integr Med. 2020 Oct 3:101215. doi: 10.1016/j.eujim.2020.101215.